Early β-Amyloid-induced Synaptic Dysfunction Is Counteracted by Estrogen in Organotypic Hippocampal Cultures

Curr Alzheimer Res. 2016;13(6):631-40. doi: 10.2174/1567205013666160125113509.

Abstract

In the present study we set up a model of slow progression of neuronal injury by exposing organotypic hippocampal cultures to a low concentration of Amyloid β (25-35) peptide (Aβ, 2 μM) to analyze the time-related effects of 17-β estradiol (17β-E2, 10 nM). Neuronal death occurs after 7 d and is prevented by addition of 17β-E2 24 h prior to, together with or 48 h after exposure to Aβ. This effect is mimicked by selective ERα agonist PPT (100 nM). Treatment with Aβ leads to early and transient (16-72 h) increase of pre- and post-synaptic proteins synaptophysin and PSD95, followed by a decrease coincident with neuronal death (7d), all prevented by 17β-E2. At 72 h of Aβ exposure, synaptic activity is increased, as by higher levels of glutamate and increased loading and unloading of FM 1-43-labeled synaptic vesicles. All these effects are also prevented by 17β-E2. These data point out beneficial effects of estrogen on early Aβ-induced synaptic disruption.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyloid beta-Peptides / toxicity*
  • Animals
  • Cell Death / drug effects
  • Cell Death / physiology
  • Estradiol / pharmacology
  • Estrogen Receptor alpha / metabolism
  • Estrogen Receptor beta / metabolism
  • Estrogens / pharmacology*
  • Glutamic Acid / metabolism
  • Hippocampus / drug effects
  • Hippocampus / pathology
  • Hippocampus / physiopathology*
  • Neuroglia / drug effects
  • Neuroglia / pathology
  • Neuroglia / physiology
  • Neurons / drug effects
  • Neurons / pathology
  • Neurons / physiology*
  • Neuroprotective Agents / pharmacology*
  • Peptide Fragments / toxicity*
  • Phenols / pharmacology
  • Pyrazoles / pharmacology
  • Rats, Sprague-Dawley
  • Synapses / drug effects
  • Synapses / pathology
  • Synapses / physiology*
  • Time Factors
  • Tissue Culture Techniques

Substances

  • Amyloid beta-Peptides
  • Estrogen Receptor alpha
  • Estrogen Receptor beta
  • Estrogens
  • Neuroprotective Agents
  • Peptide Fragments
  • Phenols
  • Pyrazoles
  • amyloid beta-protein (25-35)
  • 4,4',4''-(4-propyl-((1)H)-pyrazole-1,3,5-triyl) tris-phenol
  • Glutamic Acid
  • Estradiol